Literature DB >> 10482137

The assembly and secretion of apolipoprotein B-containing lipoproteins.

S O Olofsson1, L Asp, J Borén.   

Abstract

The assembly of lipoproteins containing apolipoprotein B is a complex process that occurs in the lumen of the secretory pathway. The process consists of two relatively well-identified steps. In the first step, two VLDL precursors are formed simultaneously and independently: an apolipoprotein B-containing VLDL precursor (a partially lipidated apolipoprotein B) and a VLDL-sized lipid droplet that lacks apolipoprotein B. In the second step, these two precursors fuse to form a mature VLDL particle. The apolipoprotein B-containing VLDL precursor is formed during the translation and concomitant translocation of the protein to the lumen of the endoplasmic reticulum. The VLDL precursor is completed shortly after the protein is fully synthesized. The process is dependent on the microsomal triglyceride transfer protein (MTP). Although the mechanism by which the lipid droplets are formed is unknown, recent observations indicate that the process is dependent on MTP. The fusion of the two precursors is not dependent on MTP, but the mechanism remains to be elucidated. The conversion of the apolipoprotein B-containing precursor to VLDL seems to be dependent on the ADP ribosylation factor 1 (ARF 1) and its activation of phospholipase D. During their assembly, nascent apolipoprotein B chains undergo quality control and are sorted to degradation. Such sorting, which occurs cotranslationally during the formation of the apolipoprotein B-containing precursor, involves cytosolic chaperons and ubiquitination that targets apolipoprotein B to proteasomal degradation. Other levels of sorting occur in the secretory pathway. Thus, lysosomal enzymes are involved as well as the LDL receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482137     DOI: 10.1097/00041433-199908000-00008

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  46 in total

1.  The identification of the SNARE complex required for the fusion of VLDL-transport vesicle with hepatic cis-Golgi.

Authors:  Shaila Siddiqi; Arul M Mani; Shadab A Siddiqi
Journal:  Biochem J       Date:  2010-07-15       Impact factor: 3.857

Review 2.  The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly.

Authors:  G F Gibbons; A M Brown; D Wiggins; R Pease
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

3.  Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.

Authors:  Mary K Wojczynski; Guimin Gao; Ingrid Borecki; Paul N Hopkins; Laurence Parnell; Chao-Qiang Lai; Jose M Ordovas; B Hong Chung; Donna K Arnett
Journal:  J Lipid Res       Date:  2010-08-19       Impact factor: 5.922

Review 4.  Hepatic regulation of apolipoprotein B.

Authors:  Rita Kohen Avramoglu; Khosrow Adeli
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

Review 5.  The physiological role of triacylglycerol hydrolase in lipid metabolism.

Authors:  Dean Gilham; Richard Lehner
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

6.  Comparison of the effects of dietary n-3 and n-6 polyunsaturated fatty acids on very-low-density lipoprotein secretion when delivered to hepatocytes in chylomicron remnants.

Authors:  X Zheng; M Avella; K M Botham
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

7.  Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients.

Authors:  Zhi-Tao Yang; Xin-Xin Zhang; Xiao-Fei Kong; Dong-Hua Zhang; Shen-Ying Zhang; Jie-Hong Jiang; Qi-Ming Gong; Gen-Di Jin; Zhi-Meng Lu
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

8.  Reticulon 3 regulates very low density lipoprotein secretion by controlling very low density lipoprotein transport vesicle biogenesis.

Authors:  Shaila Siddiqi; Olga Zhelyabovska; Shadab A Siddiqi
Journal:  Can J Physiol Pharmacol       Date:  2018-05-14       Impact factor: 2.273

9.  Common and rare gene variants affecting plasma LDL cholesterol.

Authors:  John R Burnett; Amanda J Hooper
Journal:  Clin Biochem Rev       Date:  2008-02

Review 10.  PNPLA3 genetic variation in alcoholic steatosis and liver disease progression.

Authors:  Felix Stickel; Jochen Hampe; Eric Trépo; Christian Datz; Stefano Romeo
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.